NASDAQ: SGHT - Sight Sciences, Inc.

Yield per half year: -62.34%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Sight Sciences, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Sight Sciences, Inc.

Sight Sciences, Inc., компания по производству офтальмологического медицинского оборудования, занимается разработкой и коммерциализацией хирургических и нехирургических технологий для лечения заболеваний глаз. Продукция компании включает OMNI Surgical System, терапевтическое устройство, используемое хирургами-офтальмологами для снижения внутриглазного давления у взрослых пациентов с глаукомой; и TearCare System, носимая технология век, для лечения синдрома сухого глаза (DED) для офтальмологов и оптометристов.

more details
Он предлагает продукцию через торговых представителей и дистрибьюторов больницам, медицинским центрам и офтальмологам в Соединенных Штатах. Компания была зарегистрирована в 2010 году и имеет штаб-квартиру в Менло-Парке, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-07-15
ISIN US82657M1053
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.sightsciences.com
Цена ао 3.2
Change price per day: 0% (2.93)
Change price per week: +3.53% (2.83)
Change price per month: -18.84% (3.61)
Change price per 3 month: -45.64% (5.39)
Change price per half year: -62.34% (7.78)
Change price per year: -37.79% (4.71)
Change price per 3 year: -81.98% (16.26)
Change price per 5 year: 0% (2.93)
Change price per 10 year: 0% (2.93)
Change price per year to date: -19.73% (3.65)
All parameters

Underestimation

Title Value Grade
P/S 3.2 5
P/BV 2.16 7
P/E 0 0
EV/EBITDA -2.77 0
Total: 5.13

Efficiency

Title Value Grade
ROA, % -33.33 0
ROE, % -46.21 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.6089 10
Total: 7.4

Growth impulse

Title Value Grade
Yield Revenue, % 252.42 10
Yield Ebitda, % 109.34 10
Yield EPS, % 42.78 6
Total: 9
More

Institutions Volume Share, %
JP Morgan Chase & Company 974 1.96
Apollo Management Holdings, L.P. 672 1.35
Geode Capital Management, LLC 581 1.17
State Street Corporation 445 0.89
KCK Limited 5 9.34
Bank of America Corporation 3 6.36
UBS Group AG 3 5.77
Jackson Square Partners, LLC 2 3.24
Vanguard Group Inc 2 3.13
Blackrock Inc. 1 2.88

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.05937 17.09 1.54048
Avantis U.S Small Cap Equity ETF 0.02202 27.77 1.68271
Vanguard Russell 2000 Growth ETF 0.02 23.05 0.60264
iShares Russell 2000 Growth ETF 0.01699 38.04 0.6026
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.00556 17.47 1.51433
ProShares UltraPro Russell2000 0.00508 89.82 1.47873
ProShares Hedge Replication ETF 0.00141 5.92 1.47892
Avantis U.S. Equity ETF 0.00034 23.04 1.59151
Schwab U.S. Broad Market ETF 0.00032 24.86 1.43354
Dimensional U.S. Equity ETF 0.00008 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. Paul Badawi Co-Founder, President, CEO & Director 920.3k 1975 (50 years)
Dr. David Badawi M.D. Founder, CTO & Director N/A 1970 (55 years)
Mr. Sam Boong Park Chief Operating Officer 531.78k 1961 (64 years)
Mr. Jeremy B. Hayden Chief Legal Officer N/A 1970 (55 years)
Ms. Alison Perry Bauerlein CFO & Treasurer N/A 1981 (44 years)
Mr. Steve R. Tamayo Jr. VP and Chief Ethics & Compliance Officer N/A
Mr. Stephen B. Thau J.D. Secretary N/A
Mr. Matthew W. Link Chief Commercial Officer N/A 1975 (50 years)
Dr. Reay H. Brown M.D. Chief Medical Officer
Mr. Jim Rodberg VP of Finance & Corporate Controller

Address: United States, Menlo Park. CA, 4040 Campbell Avenue - open in Google maps, open in Yandex maps
Website: https://www.sightsciences.com